Unnatural Products to be Acquired by argenx for up to $1.15 Billion to Advance Next-Generation Medicines

摘要

Argenx to acquire UNP for $550 million upfront plus contingent value rights tied to development and regulatory milestones, for total potential value of up to approximately $1.15 billion